Immunomodulatory gene networks predict treatment response and survival to de-escalated, anthracycline-free neoadjuvant chemotherapy in triple-negative breast cancer in the WSG-ADAPT-TN trial

Korbie, Darren; Stirzaker, Clare; Gluz, Oleg; zu Eulenburg, Christine; Nitz, Ulrike; Christgen, Matthias; Kuemmel, Sherko; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Wuerstlein, Rachel; Pelz, Enrico; Kreipe, Hans Heinrich; Clark, Susan J.; Trau, Matt; Graeser, Monika; Harbeck, Nadia

Immunomodulatory gene networks predict treatment response and survival to de-escalated, anthracycline-free neoadjuvant chemotherapy in triple-negative breast cancer in the WSG-ADAPT-TN trial

Autor(en):

Korbie, Darren; Stirzaker, Clare; Gluz, Oleg; zu Eulenburg, Christine; Nitz, Ulrike; Christgen, Matthias; Kuemmel, Sherko; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Wuerstlein, Rachel; Pelz, Enrico; Kreipe, Hans Heinrich; Clark, Susan J.; Trau, Matt; Graeser, Monika; Harbeck, Nadia

Tübinger Autor(en):

Grischke, Eva-Maria

Erschienen in:

Molecular Cancer (2025), Bd. 24, H. 1

Verlagsangabe:

London : Bmc

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1186/s12943-025-02275-0

ISSN:

1476-4598